Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DNM2 (clone 2E7J/DyDII). We employs the HBV (EF1α-GFP-LEF/TCF-EcoRI) vector components and the SynExpress system of the miRNA Knockout/Positive feedback for a robust and sustained response against cancers.
Host
Mouse
Target
DNM2
Clone
2E7J/DyDII
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
EF1α
Effector Gene
LEF/TCF
Insertion Sites
EcoRI
Gene Modification
Knockout
Modification Domain
miRNA
Carrier Type
HBV
Transformation Accuracy
0.95
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.